The Accuracy of CHOLINE PET CT in the Diagnosis of Urological Malignancies

NCT00706212 | Unknown

• 1 other identifier: GS-PET-2008
• Study Type: observational
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

PET CT is one of the imaging tools that are used for staging of urological malignancies. C11 Choline is a novel isotope with the advantage of its minimal secretion in the urine. This advantage makes it a potentially better metabolic marker then others such as FDG. Preliminary studies showed \~95% sensitivity in the diagnosis of TCC. Our Goal is to continue the evaluation of this method as a diagnostic and follow up tool in different urological malignancies.

Conditions

Urological Malignancies

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Rabin Medical center Urological oncology patients

You may qualify if:

• Patients older then 18 years of age
• Full consciousness and awareness
• suspected to suffer from urological malignancy and a candidate for a surgical procedur

You may not qualify if:

• known secondary malignancy

Sponsors & Collaborators

• Rabin Medical Center: lead

Study Sites (1)

Rabin Medical Center, Beilinson hospital

Petah Tikva, 49100, Israel

RECRUITING

Central Study Contacts

Shay Golan, MD

CONTACT

972-50-744-7573; shaygo1@yahoo.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: June 26, 2008
• First Posted: June 27, 2008
• Study Start: June 1, 2008
• Last Updated: June 27, 2008

Record last verified: 2008-05

Locations

IL (1)